MDT

86.26

-0.28%↓

A

114.97

-0.41%↓

VEEV

174.18

+0.18%↑

HQY

83.29

-1.55%↓

PHR.US

8.99

+7.79%↑

MDT

86.26

-0.28%↓

A

114.97

-0.41%↓

VEEV

174.18

+0.18%↑

HQY

83.29

-1.55%↓

PHR.US

8.99

+7.79%↑

MDT

86.26

-0.28%↓

A

114.97

-0.41%↓

VEEV

174.18

+0.18%↑

HQY

83.29

-1.55%↓

PHR.US

8.99

+7.79%↑

MDT

86.26

-0.28%↓

A

114.97

-0.41%↓

VEEV

174.18

+0.18%↑

HQY

83.29

-1.55%↓

PHR.US

8.99

+7.79%↑

MDT

86.26

-0.28%↓

A

114.97

-0.41%↓

VEEV

174.18

+0.18%↑

HQY

83.29

-1.55%↓

PHR.US

8.99

+7.79%↑

Search

Twist Bioscience Corp

Ouvert

SecteurSoins de santé

50.89 1.58

Résumé

Variation du prix de l'action

24h

Actuel

Min

49.56

Max

51.88

Chiffres clés

By Trading Economics

Revenu

-3.4M

-31M

Ventes

4.7M

104M

Marge bénéficiaire

-29.419

Employés

979

EBITDA

-3.2M

-24M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+5.56% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

51M

2.7B

Ouverture précédente

49.31

Clôture précédente

50.89

Sentiment de l'Actualité

By Acuity

50%

50%

141 / 349 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

Twist Bioscience Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

3 avr. 2026, 04:27 UTC

Principaux Événements d'Actualité

Singapore PM Warns That Fallout From Mideast War Could Outlast Conflict

5 avr. 2026, 23:55 UTC

Market Talk

Gold Falls Amid Dollar Strength, Inflation Worries -- Market Talk

5 avr. 2026, 23:45 UTC

Market Talk

Nikkei May Decline on Concerns About Energy Costs -- Market Talk

5 avr. 2026, 23:42 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5 avr. 2026, 23:42 UTC

Market Talk

China's Consumer Inflation Likely Eased in March -- Market Talk

5 avr. 2026, 23:38 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Rise Amid Increased Supply Disruption Concerns -- Market Talk

5 avr. 2026, 12:57 UTC

Principaux Événements d'Actualité

Some Italian Airports Report Jet-Fuel Shortages -- WSJ

3 avr. 2026, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 avr. 2026, 18:30 UTC

Principaux Événements d'Actualité

An F15-E Just Went Down in Iran. What to Know About the $30 Million Jet. -- Barrons.com

3 avr. 2026, 18:14 UTC

Market Talk

Eli Lilly Seen as Possible GLP-1 Leader With New Pill Approval -- Market Talk

3 avr. 2026, 17:50 UTC

Market Talk

Microsoft's AI Development Will Weigh on Near-Term Azure Growth -- Market Talk

3 avr. 2026, 17:44 UTC

Acquisitions, Fusions, Rachats

SBA Stock Just Had a Big Day. Why It's Suddenly Hot. -- Barrons.com

3 avr. 2026, 16:50 UTC

Principaux Événements d'Actualité

An F15-E Just Went Down in Iran. What to Know About the $90 Million Jet. -- Barrons.com

3 avr. 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 avr. 2026, 16:12 UTC

Résultats

Oil Stocks Look Tapped Out. Why It's Time to Move Into Other Sectors. -- Barrons.com

3 avr. 2026, 15:56 UTC

Market Talk
Principaux Événements d'Actualité

Crypto Markets May Be Active Over Holiday Weekend -- Market Talk

3 avr. 2026, 15:56 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

3 avr. 2026, 15:56 UTC

Market Talk
Principaux Événements d'Actualité

Global Forex and Fixed Income Roundup: Market Talk

3 avr. 2026, 15:20 UTC

Principaux Événements d'Actualité

Berkshire, Travelers Join U.S. Plan to Insure Shippers in the Hormuz Strait -- Barrons.com

3 avr. 2026, 15:08 UTC

Acquisitions, Fusions, Rachats

OpenAI Makes Surprise Media Acquisition Ahead of IPO. Why It Will Fail. -- Barrons.com

3 avr. 2026, 14:11 UTC

Market Talk
Principaux Événements d'Actualité

Oil Shock From War in Iran May Show Up In 2Q Job Growth Data -- Market Talk

3 avr. 2026, 12:56 UTC

Market Talk

Treasury Yields, Dollar Higher Following Robust March Hiring -- Market Talk

3 avr. 2026, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

3 avr. 2026, 08:01 UTC

Market Talk

Global Equities Roundup: Market Talk

3 avr. 2026, 08:01 UTC

Market Talk

Meituan's Profitability Likely to Improve This Year -- Market Talk

3 avr. 2026, 07:45 UTC

Market Talk

LG Electronics Could Post Above-Consensus 1Q Earnings -- Market Talk

3 avr. 2026, 06:17 UTC

Market Talk

Naver Likely to Post Below-Consensus 1Q Earnings -- Market Talk

3 avr. 2026, 06:17 UTC

Market Talk

Global Equities Roundup: Market Talk

3 avr. 2026, 04:33 UTC

Market Talk

China Merchants Port Earnings Likely to Recover This Year -- Market Talk

3 avr. 2026, 04:33 UTC

Market Talk

Global Equities Roundup: Market Talk

Comparaison

Variation de prix

Twist Bioscience Corp prévision

Objectif de Prix

By TipRanks

5.56% hausse

Prévisions sur 12 Mois

Moyen 53 USD  5.56%

Haut 58 USD

Bas 50 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

6 ratings

6

Achat

0

Maintien

0

Vente

Score Technique

By Trading Central

31.56 / 38.6884Support & Résistance

Court Terme

Very Strong Bearish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

141 / 349Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat